Inhibition of P-glycoprotein by natural products in human breast cancer cells
- 1 July 2005
- journal article
- research article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 28 (7) , 823-828
- https://doi.org/10.1007/bf02977349
Abstract
Multidrug resistance (MDR) is one of the most significant obstacles in cancer chemotherapy. One of the mechanisms involved in the development of MDR is the over-expression of P-glycoprotein (P-gp). It is widely known that natural compounds found in vegetables, fruits, plant-derived beverages and herbal dietary supplements not only have anticancer properties, but may also modulate P-gp activity. Therefore, the purpose of this investigation was to examine the effects of naturally occurring products on P-gp function in human breast cancer cell lines, MCF-7 (sensitive) and MCF-7/ADR (resistant). The accumulation of daunomycin (DNM), a P-gp substrate, was greater in the sensitive cells compared to the resistant cells, while the efflux of DNM was higher in the resistant cells compared to the sensitive cells over a period of 2 h. The IC50 value of DNM in the resistant cells was about 22 times higher than that in the sensitive cells, indicating an over-expression of P-gp in the resistant cells, MCF-7/ADR. All of the compounds tested, with the exception of fisetin, significantly decreased the IC50 value of DNM. Biochanin A showed the greatest increase in [3H]-DNM accumulation, increasing by 454.3±19.5% in the resistant cells, whereas verapamil, the positive control, increased the accumulation by 229.4±17.6%. Also, the accumulation of [3H]-DNM was increased substantially by quercetin and silymarin while it was reduced by fisetin. Moreover, biochanin A, silymarin, and naringenin significantly decreased DNM efflux from MCF-7/ADR cells compared with the control. These results suggest that some flavonoids such as biochanin A and silymarin may reverse MDR by inhibiting the P-gp function.Keywords
This publication has 28 references indexed in Scilit:
- P-glycoprotein: from genomics to mechanismOncogene, 2003
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Use of Complementary and Alternative Therapies in HIV-Infected PatientsAIDS Patient Care and STDs, 2001
- The P-glycoprotein multidrug transporterGeneral Pharmacology: The Vascular System, 1996
- Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytesLife Sciences, 1995
- Modulation of adriamycin® accumulation and efflux by flavonoids in HCT-15 colon cellsBiochemical Pharmacology, 1994
- ATP-DEPENDENT TRANSPORT SYSTEMS IN BACTERIA AND HUMANS: Relevance to Cystic Fibrosis and Multidrug ResistanceAnnual Review of Microbiology, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.Proceedings of the National Academy of Sciences, 1988